11-47571547-A-C
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_175732.3(PTPMT1):āc.524A>Cā(p.Gln175Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_175732.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTPMT1 | NM_175732.3 | c.524A>C | p.Gln175Pro | missense_variant | 4/4 | ENST00000326674.10 | NP_783859.1 | |
PTPMT1 | NM_001143984.2 | c.441A>C | p.Pro147Pro | synonymous_variant | 2/2 | NP_001137456.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTPMT1 | ENST00000326674.10 | c.524A>C | p.Gln175Pro | missense_variant | 4/4 | 1 | NM_175732.3 | ENSP00000325958.9 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249542Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135380
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461874Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727232
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 30, 2024 | The c.524A>C (p.Q175P) alteration is located in exon 4 (coding exon 4) of the PTPMT1 gene. This alteration results from a A to C substitution at nucleotide position 524, causing the glutamine (Q) at amino acid position 175 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at